Hero image with Pittsburgh background pittplusme.org/study/1704

STUDY BASICS

Have you been diagnosed with metastatic castration-resistant prostate cancer? If so, you may be eligible for a research study to help find out if combining two investigational drugs, called niraparib and JNJ-63723283, is effective as a treatment for metastatic prostate cancer. Reimbursement provided for travel and meals for each visit.


IRB:
  6137-LJAppleman - A Phase 1b-2 Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer

RESEARCH AREAS:
  Featured Research

Age Range
AGE:   18 and up

Duration VISITS:  Multiple visits

Location LOCATION: 
UPMC Hillman Cancer Center sites in Monroeville, Upper St. Clair, Passavant, Shadyside, & Arnold Palmer Mt. View (Greensburg), St. Margaret
Compensation COMPENSATION: 

Reimbursed between $54 to $78 per visit

Phone Number PHONE NUMBER:
1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In
Search Icon pittplusme.org/study/1704
OR
Phone Number PHONE NUMBER:
1-866-438-8230

MEET THE RESEARCHER


Leonard Appleman

Leonard J. Appleman, MD, PhD, is an Associate Professor of Medicine in the Division of Hematology/Oncology. A graduate of New York University School of Medicine, Dr. Appleman’s research interests include the development of novel therapeutics for kidney cancer, prostate cancer, and other malignancies.




PittPlusMe.org 1-866-438-8230 PittPlusMe@pitt.edu
@PittPlusMe share tweet